All three protocols use injected FSH-type drugs to grow several follicles; they differ in how they stop you from ovulating early. The antagonist protocol is now the default for most patients, and ESHRE’s 2019 guideline recommends it over agonist protocols for the general IVF population, mainly because it is equally effective and safer. The long Lupron protocol is still used in specific situations, and the microdose flare is a short agonist protocol historically used for low responders. Your doctor chooses and doses the protocol; this guide explains the logic so you can ask better questions.
The problem every protocol solves
IVF stimulation aims to grow many follicles at once, then collect the eggs just before they would naturally be released. Left alone, your brain’s LH surge could make you ovulate before retrieval and the eggs would be lost. Every protocol pairs stimulation drugs (FSH, sometimes with LH activity) with a second drug that blocks that premature surge. The three protocols differ in which blocking drug is used and when.
For the step-by-step calendar, see our IVF process guide and FertileStart’s day-by-day stimulation timeline. For the drugs themselves, see our IVF medications guide.
The three protocols side by side
| Antagonist | Long Lupron (long agonist) | Microdose flare | |
|---|---|---|---|
| Blocking drug | GnRH antagonist (for example ganirelix or cetrorelix) | GnRH agonist (leuprolide, often called Lupron) | GnRH agonist in very small doses |
| When it starts | Added partway through stimulation | Started before stimulation, often in the cycle before | Started at the beginning of stimulation |
| How it works | Blocks the pituitary immediately | Shuts the pituitary down first (“down-regulation”), then stimulation begins | Uses the agonist’s initial “flare” of the patient’s own FSH and LH to boost early stimulation |
| Typical length | Shortest | Longest | Short |
| Trigger options | hCG, agonist trigger or dual trigger | hCG; an agonist trigger will not work after down-regulation | hCG; agonist trigger usually not used |
| Often discussed for | Most patients, especially those at risk of OHSS | Selected patients and scheduling situations | Predicted or previous low responders |
The antagonist protocol
Stimulation starts early in the cycle. After several days, once follicles reach a certain size or estrogen rises, a daily antagonist injection is added to prevent an LH surge. Because the pituitary is not shut down, the antagonist protocol allows a GnRH agonist trigger, which sharply lowers the risk of ovarian hyperstimulation syndrome (OHSS) in strong responders. Our trigger shot guide explains hCG, agonist and dual triggers.
What the European Society of Human Reproduction and Embryology (ESHRE) says in its 2019 ovarian stimulation guideline:
- For the general IVF population, “the GnRH antagonist protocol is recommended over the GnRH agonist protocols” (strong recommendation), based on comparable efficacy and higher safety.
- For predicted high responders, the antagonist protocol is recommended (good practice point).
The long Lupron protocol
Leuprolide is started before stimulation, often about a week before the expected period, sometimes after a course of birth control pills. After an initial flare, it suppresses the pituitary. Once suppression is confirmed, stimulation begins while the agonist continues.
Clinicians who still use it point to predictable scheduling and very reliable prevention of premature ovulation. The downsides are more injections, a longer timeline, side effects of suppression such as headaches and hot flashes for some people, and loss of the agonist-trigger option that protects against OHSS. ESHRE’s guideline also notes that if agonist protocols are used in predicted high responders, a reduced gonadotropin dose is probably recommended. Among agonist protocols, ESHRE says the long protocol is probably recommended over short or ultrashort agonist protocols.
The microdose flare protocol
In the flare protocol, very small doses of leuprolide are started at the beginning of the cycle together with stimulation drugs. The idea is to harness the agonist’s initial surge of the patient’s own FSH and LH to recruit more follicles, and then rely on the continuing agonist to prevent early ovulation. It has mostly been used for people who responded poorly to standard protocols.
The evidence is mixed. ESHRE’s 2019 guideline states that GnRH antagonists and GnRH agonists are “equally recommended” for predicted poor responders, and it does not single out the microdose flare as superior. In practice, many clinics now try an antagonist protocol, a change in dose or drug mix, or milder stimulation first. Our guide to diminished ovarian reserve protocol options compares those choices.
Other variations you may hear about
Clinics adapt these basic designs constantly, so your calendar may not match any textbook version exactly. Common variations include:
- Pretreatment with birth control pills or estrogen. Used to time the start of a cycle or to coordinate follicle growth. Some patients start antagonist cycles this way too.
- Progestin-primed stimulation. An oral progestin is used instead of an antagonist or agonist to prevent the LH surge. Because the progestin affects the uterine lining, embryos are frozen and transferred in a later cycle.
- Mild or minimal stimulation. Lower doses or oral drugs, accepting fewer eggs for lower drug cost and fewer side effects. See our mini IVF guide.
- Adding LH activity or growth hormone. Sometimes added for low responders; ask what evidence your clinic relies on, because these add-ons are debated.
What a protocol cannot change
A protocol can influence how many follicles grow and how safely the cycle runs. It cannot change the chromosomal quality of eggs, which is driven mainly by age. That is why switching protocols after a poor cycle sometimes helps (if the problem was timing, early ovulation or under-dosing) and sometimes does not (if the main limit is ovarian reserve or egg quality). It is fair to ask your doctor which of those they think was the problem last time.
How doctors usually choose
- Predicted response. AMH, antral follicle count, age and any previous cycles help estimate whether you are likely to be a high, normal or low responder. FertileStart’s guide to the baseline appointment covers what is checked before you start.
- OHSS risk. High responders, including many people with PCOS or PMOS, are typically steered to an antagonist protocol so an agonist trigger and freeze-all strategy are available. See our OHSS prevention guide.
- What happened last time. If a previous cycle produced few eggs, ovulated early or overstimulated, the protocol is usually changed.
- Plan for transfer. If a freeze-all is planned, a fresh-transfer advantage of one protocol may not matter.
- Clinic experience and logistics. Scheduling, cost of drugs and each clinic’s own results also play a role.
Expect an antagonist protocol unless there is a specific reason for something else.
- Usually discussed when
- Planning a first IVF cycle or redesigning one after a poor, early or excessive response.
- Main upside
- Antagonist cycles are shorter and keep the safer agonist-trigger option open.
- Main tradeoff
- Agonist protocols may suit some patients or schedules, but add injections and remove the agonist-trigger option.
- Which protocol are you recommending, and why for me specifically?
- Do you expect me to be a high, normal or low responder, and what is that based on?
- If I overrespond, which trigger and transfer plan would you use?
- If this cycle goes poorly, what would you change next time?
- Are you planning a fresh transfer or freeze-all, and does that change the protocol choice?
- Is a milder or lower-dose approach reasonable for me, and what would I give up?
Monitoring scans drive most mid-cycle decisions; FertileStart’s guide to reading your monitoring ultrasound explains the numbers you will see.
Ask how each clinic would stimulate you
Some patients compare accredited clinics in Colombia alongside US options. Ask any clinic which protocol it would use for you and why, and request a written all-in quote that includes medications, monitoring and embryo freezing, plus its age-specific outcome data.
Questions? Message us on WhatsApp and we’ll point you to clinics and next steps. We may earn referral fees from partner clinics.
Frequently asked questions
Which IVF protocol has the best success rate?
For the general IVF population, ESHRE found antagonist and agonist protocols comparable in effectiveness and recommends antagonist protocols because they are safer. The best protocol for you depends on your predicted response and history.
Is the long Lupron protocol outdated?
It is used less often than before, but it is still chosen for some patients and situations. ESHRE says that among agonist protocols, the long protocol is probably preferred over short or ultrashort versions.
Is the microdose flare protocol better for poor responders?
Not clearly. ESHRE’s 2019 guideline says antagonist and agonist protocols are equally recommended for predicted poor responders, so the choice is usually individualized.
Why does an antagonist protocol lower OHSS risk?
It allows a GnRH agonist trigger instead of hCG, which lowers the risk of ovarian hyperstimulation syndrome in strong responders. That option is not available after long agonist down-regulation.
Can I ask to switch protocols?
Yes. It is reasonable to ask why a protocol was chosen and what the alternatives are, especially after a cycle with a poor or excessive response.